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Background: Cancer is the leading cause of 
morbidity and mortality worldwide, with 
approximately 18.1 million new cases and 9.6 
million deaths in 2018. The major type of 
cancer among females is breast cancer, 
accounting for 24.2% of the total cancer 
cases. In the last decades, phytochemicals 
have attracted a growing attention as anti-
cancer agents and the study of herbal 
formulations from traditional medicine 
represents a challenging research field.  
 
Objectives: Shemamruthaa (SM), an 
indigenous herbal formulation constituting 
petals of Hibiscus rosa-sinensis and fruits of 
Emblica officinalis and honey was evaluated 
for anticancer property. 
 
Methods: Adult female Sprague-Dawley rats 
(8-week-old) were used for the study and 
were divided into 4 groups. Group I, normal 
control animals received a single oral dose of 
olive oil (1 ml) at the age of eight weeks 
(Control); Group II animals induced for 
mammary carcinoma with a single oral dose 
of 25 mg of 7, 12- dimethylbenz (a) 
anthracene DMBA dissolved in one ml of olive 
oil after overnight fasting. Group III 
mammary carcinoma was induced as in 
Group II, in addition, after three months; 
animals were treated with SM at the dose of 
400 mg/ kg body weight/day by gastric 
intubation (DMBA+ SM treated). Group IV 
Animals received 400 mg/kg body weight of 
SM alone and served as SM control. The 
experimental design was performed in 
accordance with the current ethical norms 
approved by the Committee for the Purpose 
of Control and Supervision of Experiments on 
Animals (CPCSEA), and Institutional Animal 
Ethics Committee Guidelines (IAEC. No. 
01/030/2011). The tumour markers and the 
mRNA expression of pro-apoptotic 
genes/anti-apoptotic genes were examined 
by RT-PCR analysis in mammary tissues of 
control and experimental animals.  
 
Results: Results of the study revealed that SM 
treatment significantly (p< 0.05) abridged the 
levels of tumour markers viz. 
carcinoembryonic antigen (CEA) and breast 
cancer specific marker (CA-15-3) when 
compared to DMBA-induced rats. SM 
treatment significantly induced mRNA levels 
of p53 and Bax. Meanwhile, the cell 
proliferative (PCNA) and anti-apoptotic gene, 
Bcl-2 were down-regulated by SM treatment.  
 
Conclusion: The expression pattern of breast 
cancer markers and apoptotic signaling 
molecules analyzed in the present study 
signifies the therapeutic efficacy of SM 
against breast cancer.  
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